Hui Guo

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Clinical and translational medicine

PloS one

Technology in cancer research & treatment

Immunotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China. Clinical and translational medicine 13 (12) (2023)
Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China. Clinical and translational medicine 13 (12) (2023)
Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China. Clinical and translational medicine 13 (12) (2023)
Yanlin Li, Xiaohui Jia, Yajuan Zhang, Yonghao Du, Yuzhu Chang, Yuan Shen, Ziyang Mao, Mengjie Liu, Hong Sun, Hui Guo
Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis. Journal for immunotherapy of cancer 11 (6) (2023)
Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China. Clinical and translational medicine 13 (12) (2023)
Panpan Jiang, Luying Geng, Ziyang Mao, Qinyang Wang, Wenjuan Wang, Min Jiao, Na Liu, Nanzheng Chen, Jia Zhang, Kejun Nan, Yuan Shen, Hui Guo, Lili Jiang
First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions. Immunotherapy (2022)
SiZhe Yu, Yu Wang, KeJia Lv, Jia Hou, WenYuan Li, Xiao Wang, Hui Guo, WenJuan Wang
NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway. Technology in cancer research & treatment 20 (2022)
SiZhe Yu, Yu Wang, Jia Hou, WenYuan Li, Xiao Wang, LuoChengLing Xiang, DeLi Tan, WenJuan Wang, LiLi Jiang, Francois X Claret, Min Jiao, Hui Guo
Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival. PloS one 15 (4) (2020)

Hui Guo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui Guo